| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-07 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.35 | 8e-07 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.32 | 2e-06 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-06 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-06 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-06 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.17 | 9e-06 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.31 | 1e-05 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0002 |